Eagle Health is an ASX listed vertically integrated health and nutritional products business which develops, manufactures and distributes products into 26 provinces in China. 

Eagle Health produces
a range of traditional Chinese Medicine and
Western nutritional products including amino
acids, protein supplements, lozenges and
dendrobium oil. Eagle Health has a GMP certified manufacturing facility and a Head Office in Xiamen, China, acting as a central hub for distribution into Chinese pharmacies, health food stores, trading companies and supermarkets. Eagle Health has a corporate and sales office in Melbourne, Australia.

Eagle Health has a stated strategy of acquiring or partnering with quality Australian products for distribution into China.  

Key Investment Highlights 

• The Company seeks to raise a up to $1 million (before costs) by issuing up to approximately 10 million new fully paid ordinary shares in the Company (“New Shares”) by way of a single tranche Placement. The Company reserves the right to accept oversubscriptions. 
• Placement shares will be issued under the Company’s current placement capacity pursuant to ASX Listing Rules 7.1.  

Term Sheet and Application Details will be emailed to Wholesale investors.